- Home
- ELLO vs IKT Comparison
ELLO vs IKT Comparison
Compare ELLO & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELLO
- IKT
- Stock Information
- Founded
- ELLO 1987
- IKT 2008
- Country
- ELLO Israel
- IKT United States
- Employees
- ELLO N/A
- IKT N/A
- Industry
- ELLO Electric Utilities: Central
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- ELLO Utilities
- IKT Health Care
- Exchange
- ELLO Nasdaq
- IKT Nasdaq
- Market Cap
- ELLO 208.2M
- IKT 168.0M
- IPO Year
- ELLO 1995
- IKT 2020
- Fundamental
- Price
- ELLO $15.24
- IKT $2.09
- Analyst Decision
- ELLO
- IKT Buy
- Analyst Count
- ELLO 0
- IKT 2
- Target Price
- ELLO N/A
- IKT $8.00
- AVG Volume (30 Days)
- ELLO 2.6K
- IKT 111.4K
- Earning Date
- ELLO 06-30-2025
- IKT 05-14-2025
- Dividend Yield
- ELLO N/A
- IKT N/A
- EPS Growth
- ELLO N/A
- IKT N/A
- EPS
- ELLO N/A
- IKT N/A
- Revenue
- ELLO $41,895,641.00
- IKT N/A
- Revenue This Year
- ELLO N/A
- IKT N/A
- Revenue Next Year
- ELLO N/A
- IKT N/A
- P/E Ratio
- ELLO N/A
- IKT N/A
- Revenue Growth
- ELLO N/A
- IKT N/A
- 52 Week Low
- ELLO $11.08
- IKT $1.12
- 52 Week High
- ELLO $20.81
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- ELLO 52.43
- IKT 50.06
- Support Level
- ELLO $14.50
- IKT $1.78
- Resistance Level
- ELLO $18.30
- IKT $2.37
- Average True Range (ATR)
- ELLO 0.76
- IKT 0.16
- MACD
- ELLO 0.06
- IKT -0.00
- Stochastic Oscillator
- ELLO 29.33
- IKT 54.70
About ELLO Ellomay Capital Ltd (Israel)
Ellomay Capital Ltd is focused on the utility sector. It is an Israeli public company, which focuses its business in the energy and infrastructure sectors. The company's operating segment includes Photovoltaic power plants (PV Plants); Dorad Energy Ltd. (Dorad); Groen Gas Goor B.V. and a Pumped storage hydro power plant (Manara). It generates maximum revenue from the Dorad segment. Geographically, it derives a majority of its revenue from Spain.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.